Kyverna Therapeutics, Inc. Common Stock

KYTXNASDAQ • USD
5.45 USD
↗ 0.40 (7.90%)🟢PRE MARKET (AS OF 04:07 AM EST)
🟢Market: OPEN

Kyverna Therapeutics, Inc. Common Stock (KYTX) trades at $5.45 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest KYTX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$5.26
High?$5.45
Low?$5.26
Prev. Close?$5.05
Volume?0
Avg. Volume?850.0K
Bid / Ask
Bid?$4.33 × 100
Ask?$6.23 × 100
Spread?$1.90
Midpoint?$5.28
Valuation & Ratios
Market Cap?319.3M
Shares Out?63.2M
Float?35.8M
Float %?57.9%
P/E Ratio?N/A
P/B Ratio?1.93
EPS?-$2.41
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Employees
149
Market Cap
319.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA
Phone: (510) 925-2492
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
77
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.06Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.39%Squeeze Risk
Short Interest?9.1M
Days to Cover?11.6
Free Float35.8M
Avg Daily Volume784.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.06Strong
Quick Ratio?9.06Strong
Cash Ratio?1.39Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
76
1.93CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-92.2%WEAK▾
ROA?
S&P
3
-69.4%WEAK▾
Cash Flow & Enterprise
FCF?$-159045000
Enterprise Value?$312.5M
Fundamentals ratios updated end of day